STOCK TITAN

Elutia Inc. Form 4 Filings

ELUT NASDAQ

Every Form 4 that Elutia Inc. (ELUT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ELUT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ELUT filings page.

Rhea-AI Summary

ELUTIA INC. President and CEO C. Randal Mills reported compensation-related equity activity involving restricted stock units that vested into Class A Common Stock. On this vesting, 22,473 shares were issued upon conversion of restricted stock units, and 8,064 of those shares were withheld by the company to cover tax obligations. These transactions were recorded as an option-style exercise and a tax-withholding disposition rather than open-market buying or selling. After the transactions, Mills directly held 441,180 shares of Class A Common Stock, indicating he retained most of the newly vested shares as ongoing equity exposure.

Rhea-AI Summary

Elutia Inc. director and ten percent owner Kevin Rakin reported receiving a grant of stock options covering 159,590 shares of Class A Common Stock at an exercise price of $0.96 per share. The options vest on the earlier of the day before the first annual meeting after grant or the first anniversary, subject to his continued board service, and expire on June 11, 2036. Following this award, he holds 159,590 derivative securities directly.

Rhea-AI Summary

ELUTIA INC. director David Colpman received a grant of stock options covering 106,393 shares of Class A Common Stock at an exercise price of $0.96 per share. The grant is compensation, not an open-market trade, and was awarded at no cost to him.

These options vest and become exercisable on the earlier of the day immediately preceding Elutia’s first annual meeting following the grant date or the first anniversary of the grant date, provided he continues serving on the board through the vesting date. The options expire on June 11, 2036.

Rhea-AI Summary

ELUTIA INC. director Guido J. Neels received a grant of stock options covering 106,393 shares of Class A common stock. The options have an exercise price of $0.96 per share and expire on June 11, 2036.

The grant was made automatically under the company’s Non-Employee Director Compensation Program. These options vest and become exercisable on the earlier of the day immediately preceding the company’s first annual meeting following the grant date or the first anniversary of the grant date, if he continues serving on the board.

Rhea-AI Summary

ELUTIA INC. director Brigid Makes reported receiving a stock option grant as part of the company’s Non-Employee Director Compensation Program. The award covers 106,393 shares of Class A common stock at an exercise price of $0.9600 per share and expires on June 11, 2036. The option vests and becomes exercisable on the earlier of the day immediately preceding Elutia’s first annual meeting following the grant date or the first anniversary of the grant date, subject to her continued service on the board. This is a compensation-related grant and not an open-market share purchase.

Rhea-AI Summary

ELUTIA INC. Chief Scientific Officer Michelle LeRoux Williams reported routine equity compensation activity. On June 10, 2026, 12,500 restricted stock units vested into Class A Common Stock, and 4,269 shares were withheld at $1.04 per share to cover tax obligations. Following these transactions, she directly holds 118,052 Class A shares and 25,000 restricted stock units, from an original grant of 150,000 units awarded on January 31, 2024 with a scheduled vesting through December 10, 2026.

Rhea-AI Summary

ELUTIA INC. chief financial officer Matthew Ferguson reported routine equity compensation activity involving restricted stock units that vested into Class A common stock. On the vesting date, 12,500 RSUs converted into 12,500 shares of Class A common stock, as each unit represents one share.

The company withheld 4,485 of these shares at an implied price of $1.04 per share to cover tax withholding obligations, which is recorded as a disposition but not an open-market sale. After these transactions, Ferguson directly owned 480,082 shares of Class A common stock and held 25,000 restricted stock units as of the report.

Rhea-AI Summary

ELUTIA INC. President and CEO C. Randal Mills reported routine equity compensation activity tied to restricted stock units (RSUs). On June 10, 2026, 27,083 RSUs converted into an equal number of Class A common shares, reflecting a scheduled vesting.

To satisfy tax withholding on this vesting, the issuer withheld 9,718 Class A shares at an indicated value of $1.04 per share, a disposition categorized as payment of tax liability rather than an open-market sale. Following these transactions, Mills directly holds 426,771 Class A shares and 216,666 RSUs.

Footnotes explain that these RSUs were part of a 487,500-unit grant made on January 31, 2024. RSUs covering 162,500 shares vest only if the stock trades at or above $6.00, $10.00, $14.00 and $18.00 for twenty consecutive trading days, while 325,000 time-based RSUs vest on a specified schedule through December 10, 2026, subject to Mills’ continued employment.

Rhea-AI Summary

ELUTIA INC. director and ten percent owner Kevin Rakin, together with affiliated HighCape entities, reported internal share movements rather than market trades in Class A Common Stock. On June 1, a bona fide gift transferred 70,000 shares, leaving 126,120 shares held directly afterward. A separate 50,000-share transaction reflects a distribution by trusts to their beneficiaries without payment of consideration, with 272,419 shares then held indirectly through trusts. An additional 4,706,559 shares are reported as indirectly held through HighCape investment entities. Footnote disclosures state that Mr. Rakin and the HighCape reporting persons may be deemed to beneficially own these indirect holdings but each disclaims beneficial ownership except to the extent of any pecuniary interest.

Rhea-AI Summary

ELUTIA INC. director Guido J. Neels exercised restricted stock units that vested into 6,250 shares of Class A Common Stock at a price of $0.00 per share. These shares came from a grant of 25,000 restricted stock units that vests in four equal installments. Following this vesting and conversion, Neels directly owns 125,000 shares of Class A Common Stock.

Rhea-AI Summary

Elutia Inc.’s Chief Scientific Officer, Michelle LeRoux Williams, increased her direct equity stake through restricted stock unit vesting. On March 10, 2026, 12,500 restricted stock units converted into an equal number of Class A Common shares, reflecting previously granted equity compensation.

To cover tax withholding on this vesting, 4,613 shares of Class A Common Stock were withheld by the company at a price of $1.09 per share, leaving a net 7,887 newly held shares. Following these routine compensation-related transactions, she directly owns 109,821 shares of Class A Common Stock and 37,500 restricted stock units, each representing a contingent right to receive one share.

Rhea-AI Summary

Elutia Inc.’s chief financial officer Matthew Ferguson reported routine equity compensation activity. On March 10, 2026, 12,500 restricted stock units vested and were exercised into 12,500 shares of Class A Common Stock. To cover tax obligations on this vesting, 5,123 shares were withheld by the company at a price of $1.09 per share, leaving a net increase of 7,377 shares. After these transactions, Ferguson directly owns 472,067 shares of Class A Common Stock. The vested RSUs are part of a 150,000-unit grant awarded on January 31, 2024, which vests in scheduled installments through December 10, 2026.

Rhea-AI Summary

Elutia Inc. President and CEO C. Randal Mills reported compensation-related stock activity. On 2026-03-10, restricted stock units vested, resulting in the acquisition of 27,084 shares of Class A Common Stock, with each unit representing one share. The issuer withheld 11,100 shares at $1.09 per share to cover tax obligations associated with the vesting. Following these transactions, Mills directly holds 409,406 shares of Class A Common Stock, indicating a routine equity award vesting and related tax withholding rather than an open-market trade.

Rhea-AI Summary

Elutia Inc. insider Kevin L. Rakin and affiliated HighCape entities reported recent share activity in Elutia Class A Common Stock. On January 30, 2026, a reporting person purchased 70,000 shares at a weighted average price of $1.06 per share, with individual trade prices ranging from $1.05 to $1.08. Following this purchase, 196,120 shares were held directly. The filing also reports 322,419 shares held indirectly by trusts and 4,706,559 shares indirectly held through HighCape-related entities, which may be deemed beneficially owned as described in the footnotes, subject to customary beneficial ownership disclaimers.

Rhea-AI Summary

Elutia Inc. director Guido J. Neels reported an open-market purchase of Class A common stock. On January 30, 2026, he bought 20,000 shares of Elutia at a weighted average price of $1.04 per share, with individual trade prices ranging from $1.03 to $1.07. Following this transaction, he beneficially owned 118,750 shares of Elutia Class A common stock held directly.

Rhea-AI Summary

Elutia Inc. director Guido J. Neels reported open-market purchases of the company’s Class A common stock on two consecutive days. On January 28, 2026, he bought 15,000 shares at a weighted average price of $1.06, with individual trades ranging from $1.00 to $1.10, bringing his holdings to 83,750 shares.

On January 29, 2026, he purchased another 15,000 shares at a weighted average price of $1.06, from $1.03 to $1.10 per share. After these transactions, Neels directly owned 98,750 Class A common shares of Elutia Inc.

Rhea-AI Summary

Elutia Inc. director reports open-market share purchase

A director of Elutia Inc. (ELUT) reported buying Class A common stock in a personal capacity. On 12/17/2025, the reporting person purchased 12,500 shares of Elutia Class A common stock at a price of $0.51 per share. After this transaction, the director beneficially owned 31,098 shares of Class A common stock held directly.

Rhea-AI Summary

Elutia Inc. director Brigid Makes reported an open-market purchase of Class A common stock. On 12/17/2025, the reporting person bought 25,000 Class A shares at a weighted average price of $0.52 per share, with individual trade prices ranging from $0.51 to $0.53. After this transaction, the director beneficially owns 27,000 Class A shares, held directly. The filing notes that detailed trade-by-trade pricing within the reported range is available upon request.

Rhea-AI Summary

Elutia Inc. insider C. Randal Mills, who serves as president, CEO, and director, reported buying additional company stock. On 12/17/2025, he acquired 3,000 shares of Elutia Class A common stock in an open-market purchase at $0.51 per share. Following this transaction, he directly beneficially owns 379,204 shares of the company’s Class A common stock.

Rhea-AI Summary

Elutia Inc.'s Chief Financial Officer, Matthew Ferguson, reported buying additional company stock. On 12/17/2025, he purchased 60,000 shares of Elutia Inc. Class A common stock in an open market transaction coded as a purchase, at a weighted average price of $0.53 per share, with individual trade prices ranging from $0.51 to $0.54.

Following this transaction, Ferguson beneficially owns 447,110 shares of Elutia Inc. common stock, held directly. The filing notes that detailed breakdowns of the number of shares purchased at each separate price within the reported range are available upon request to the company, any security holder, or SEC staff.

Rhea-AI Summary

Elutia Inc. director and 10% owner Kevin Rakin filed an amended insider ownership report describing an in-kind distribution of Class A common stock from HighCape investment entities on December 11, 2025.

On that date, HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC distributed all of their Elutia Class A shares to their partners and members pro rata, without payment of consideration. Rakin received 126,120 shares directly and his irrevocable trusts received 181,612 shares. The filing states that the distribution resulted in a change in the form of his beneficial ownership only.

Footnotes explain Rakin’s indirect holdings through multiple HighCape-affiliated entities and trusts, and the amendment corrects an earlier Form 4 that had misstated the number of shares distributed by the HighCape entities.

Rhea-AI Summary

Elutia Inc. director and 10% owner Kevin Rakin reported a pro rata distribution of Class A common stock on 12/11/2025. HighCape investment entities distributed 4,372,497 shares of Elutia Class A stock to their partners and members without payment of consideration.

As part of this distribution, Rakin personally received 126,120 shares and his irrevocable trusts received 181,612 shares. Following the transaction, he beneficially owns 4,978,978 Elutia shares through various HighCape entities and trusts, and the distribution is described as being without payment of consideration and as a change in the form of his beneficial ownership only.

Rhea-AI Summary

Elutia Inc. chief scientific officer Michelle LeRoux Williams reported routine equity compensation activity. On 12/10/2025, 12,500 restricted stock units converted into shares of Class A common stock, increasing her direct holdings. The company then withheld 3,951 shares at $ 0.7 per share to cover tax obligations, leaving her with 101,934 Class A shares held directly and 50,000 restricted stock units outstanding.

These vested units are part of a 150,000 restricted stock unit grant dated 01/31/2024, which vests in scheduled installments from 06/10/2024 through 12/10/2026.

Rhea-AI Summary

Elutia Inc.'s chief financial officer Matthew Ferguson reported equity awards activity on December 10, 2025. He acquired 12,500 shares of Class A common stock upon vesting of restricted stock units, with 4,461 shares withheld by the company to satisfy tax withholding requirements.

After these transactions, Ferguson directly owned 387,110 shares of Elutia Class A common stock and held 50,000 restricted stock units as derivative securities. The vested units are part of a 150,000-unit restricted stock grant awarded on January 31, 2024 that vests as to 1/6 on June 10, 2024 and as to 1/12 quarterly through December 10, 2026.

Rhea-AI Summary

Elutia Inc. President, CEO and director C. Randal Mills reported the vesting of 27,083 restricted stock units into shares of the company’s Class A common stock on December 10, 2025. After this transaction, he directly owned 376,204 Class A shares and 270,833 restricted stock units.

Of the shares delivered at vesting, 9,664 shares were withheld by Elutia to satisfy tax withholding requirements, with the remaining shares retained by Mills. The filing notes that these units are part of a 487,500‑unit restricted stock grant awarded on January 31, 2024, which vests over time and upon the stock reaching price targets of $6.00, $10.00, $14.00 and $18.00 for twenty consecutive trading days, subject to his continued employment and the company’s trading‑window restrictions.

Rhea-AI Summary

Elutia Inc. (ELUT) reported an insider stock purchase by its President and CEO, who is also a director. On 11/24/2025, the reporting person acquired 5,000 shares of Elutia Class A common stock in an open-market purchase at a price of $0.60 per share. Following this transaction, the reporting person beneficially owns 358,785 shares of Class A common stock in direct ownership form.

Rhea-AI Summary

Elutia Inc. (ELUT) director David Colpman reported buying additional shares of the company’s Class A common stock. On 11/17/2025, he purchased 15,500 shares at a price of $0.74 per share. Following this transaction, he beneficially owned 18,598 shares, held as a direct ownership position. This filing reflects an insider open-market purchase rather than a sale.

Rhea-AI Summary

Elutia Inc. (ELUT) reported a director stock option grant covering 171,916 shares at an exercise price of $0.88 on October 9, 2025. The option vests in three equal annual installments and becomes fully exercisable on October 9, 2028, with an expiration date of October 9, 2035. After the grant, 171,916 derivative securities were beneficially owned, held directly.